Login to Your Account

Clinic Roundup

Wednesday, January 30, 2013
• OncoPep Inc., of Boston, said it started a Phase I/IIa trial testing PVX-410, a multipeptide therapeutic cancer vaccine, in patients with smoldering multiple myeloma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription